External Micropulse Diode Laser Transscleral Trabeculoplasty (EMDLT) for Severe Open Angle Glaucoma

National University Health System (NUHS)

Status and phase: Unknown; Early Phase 1

Conditions: Primary Open Angle Glaucoma

Treatments: Device: EXTERNAL MICROPULSE DIODE LASER TRANSSCLERAL TRABECULOPLASTY

Study type: Interventional

Funder types: Other

Identifiers

NCT00443664

DSRB-A/06/165

Details and patient eligibility

About

To prove that external contact micropulse diode laser trabeculoplasty (EMDLT) can significantly lower intraocular pressure in cases of advanced open angle glaucoma.

Full description

Micropulse diode laser trabeculoplasty applied through a gonioscopy len has been shown to be effective in lower the pressure for patients with primary open angle glaucoma (POAG). We believe that applied externally, the contact diode micropulse laser will be effective in lowering intraocular pressure for patients with advance open angle glaucoma with minimal side effects

Enrollment: 30 estimated patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• • Diagnosis of Primary Open Angle Glaucoma

  • Advanced glaucoma with intraocular pressure higher than 21mmHg on one or more topical medications (for at least 2 months)
  • Visual acuity worse than 6/6
  • Age more than 21 years
  • Poor candidate for additional filtration surgery

Exclusion criteria

• • Age less than 21 years

  • Any eye surgery within 2 months of enrolment
  • Any patient with rubeosis
  • Unable to give informed consent

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)